Stryker Corporation $SYK Shares Purchased by Chesley Taft & Associates LLC

Chesley Taft & Associates LLC raised its holdings in Stryker Corporation (NYSE:SYK) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 141,083 shares of the medical technology company’s stock after purchasing an additional 3,230 shares during the quarter. Stryker accounts for about 2.0% of Chesley Taft & Associates LLC’s holdings, making the stock its 9th biggest position. Chesley Taft & Associates LLC’s holdings in Stryker were worth $49,586,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Clayton Financial Group LLC purchased a new stake in shares of Stryker in the third quarter valued at approximately $26,000. United Financial Planning Group LLC purchased a new position in Stryker in the third quarter worth $27,000. Elevation Point Wealth Partners LLC acquired a new stake in Stryker in the second quarter valued at $28,000. Kilter Group LLC purchased a new stake in shares of Stryker during the 2nd quarter worth $29,000. Finally, Howard Hughes Medical Institute purchased a new stake in shares of Stryker during the 2nd quarter worth $29,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

SYK has been the subject of a number of research analyst reports. William Blair reiterated an “outperform” rating on shares of Stryker in a report on Thursday, March 5th. UBS Group decreased their price objective on shares of Stryker from $400.00 to $380.00 and set a “neutral” rating on the stock in a report on Tuesday, March 17th. Sanford C. Bernstein upped their target price on shares of Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a research report on Friday, January 9th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 22nd. Finally, Citizens Jmp raised Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 price target on the stock in a research note on Friday, December 19th. Fourteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $427.50.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the transaction, the director owned 2,457,331 shares of the company’s stock, valued at approximately $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 5.90% of the company’s stock.

Stryker Stock Performance

NYSE:SYK opened at $327.49 on Friday. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $125.42 billion, a P/E ratio of 38.99, a price-to-earnings-growth ratio of 1.91 and a beta of 0.85. The firm has a 50-day moving average price of $360.17 and a two-hundred day moving average price of $363.70. Stryker Corporation has a twelve month low of $324.93 and a twelve month high of $404.87.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating the consensus estimate of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The business had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. During the same period in the prior year, the business earned $4.01 earnings per share. The company’s quarterly revenue was up 11.4% on a year-over-year basis. As a group, research analysts expect that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Tuesday, March 31st. Stryker’s dividend payout ratio is 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.